IP Library Granted Patent US 8,722,928
Granted Patent B2
US 8,722,928 · App. 13/447,715 · Granted May 13, 2014

Stable and non-precipitating aqueous compositions containing the potassium salt of (S)-(+)-abscisic acid, and methods of their preparation and use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,722,928
App. No.
13/447,715
Granted
May 13, 2014
Kind
B2
Abstract

The present invention generally relates to aqueous compositions containing salts of (S)-(+)-abscisic acid, the surfactant Atlox™ 4913, and the color stabilizers sodium citrate and sodium acetate, methods of their preparation, and methods of their agricultural use.

Claims (13)

1. An aqueous composition for the treatment of plants comprising at least about 0.25 weight % of the composition of (S)-(+)-abscisic acid as a potassium salt, an effective amount of sodium citrate, an effective amount of sodium acetate, an effective amount of Atlox™ 4913, an effective amount of potassium sorbate, and optionally one or more performance enhancing additives.

2. The composition of claim 1 wherein the composition comprises from about 0.25 to about 45 weight % of (S)-(+)-abscisic acid as the potassium salt.

3. The composition of claim 1 wherein the composition comprises about 10.0 weight % of (S)-(+)-abscisic acid as the potassium salt.

4. The composition of claim 1 wherein the composition comprises from about 0.1 to about 1.0 weight % of sodium citrate and from about 0.1 to about 1.0 weight % of sodium acetate.

5. The composition of claim 1 wherein the composition comprises from about 0.01 to about 1.0 weight % potassium sorbate, from about 0.2 to about 1.0 weight % sodium citrate, and from about 0.2 to about 1.0 weight % of sodium acetate.

6. The composition of claim 1 wherein the composition comprises from about 0.02 to about 40.0 weight % of Atlox™ 4913.

7. The composition of claim 1 , wherein the composition comprises from about 0.25 to about 45 weight % of (S)-(+)-abscisic acid as the potassium salt, from about 0.1 to about 1.0 weight % of sodium citrate, from about 0.1 to about 1.0 weight % of sodium acetate, from about 0.02 to about 40.0 weight % of Atlox™ 4913, and from about 0.01 to about 1.0 weight % of potassium sorbate.

8. The composition of claim 1 , wherein the composition comprises from about 5 to about 20 weight % of (S)-(+)-abscisic acid as the potassium salt, from about 0.25 to about 0.75 weight % of sodium citrate, from about 0.25 to about 0.75 weight % of sodium acetate, from about 0.10 to about 1.0 weight % of Atlox™ 4913, and from about 0.1 to about 0.75 weight % of potassium sorbate.

9. The composition of claim 1 , wherein the composition comprises about 10.0 weight % of (S)-(+)-abscisic acid as the potassium salt, about 0.5 weight % of sodium citrate, about 0.5 weight % of sodium acetate, about 0.25 weight % of Atlox™ 4913, and about 0.25 weight % of potassium sorbate.

10. The composition of claim 9 , wherein the composition comprises about 87.0 weight % of water.

11. An aqueous composition comprising (S)-(+)-abscisic acid as a potassium salt at a concentration from about 0.25% to about 45.00% by weight, sorbate at a concentration from about 0.0007 M to about 0.0666 M, citrate at a concentration from about 0.0034 M to about 0.0340 M, acetate at a concentration from about 0.0122 M to about 0.1219 M, Atlox™ 4913 at a concentration from about 0.02% to about 10.00%, further comprising from about 0.0224 M to about 0.2239 M sodium, and from about 0.0101 M to about 1.7691 M potassium, and from about 35.34% to about 99.48% by weight water, wherein the pH of the aqueous composition is from about 6.0 to about 7.0.

12. The aqueous composition of claim 11 wherein (S)-(+)-abscisic acid as a potassium salt at a concentration from about 5.0% to about 20.0% by weight, sorbate at a concentration from about 0.0067 M to about 0.0499 M, citrate at a concentration from about 0.0085 M to about 0.0255 M, acetate at a concentration from about 0.0305 M to about 0.0914 M, Atlox™ 4913 at a concentration from about 0.10% to about 1.00%, further comprising from about 0.0560 M to about 0.1679 M sodium, and from about 0.1958 M to about 0.8066 M potassium, and from about 73.79% to about 93.56% by weight water, wherein the pH of the aqueous composition is from about 6.0 to about 7.0.

13. The aqueous composition of claim 11 wherein the (S)-(+)-abscisic acid as a potassium salt is at a concentration of about 10% by weight, sorbate is at a concentration of about 0.0166 M, citrate is at a concentration of about 0.0170 M, acetate is at a concentration of about 0.0610 M, Atlox™ 4913 is at a concentration of about 0.25% by weight, further comprising about 0.1120 M sodium ions, about 0.3950 M potassium ions, and about 87.02% water by weight, wherein the pH of the aqueous composition is from about 6.1 to 6.6.

Assignments (2)
MERGER Recorded May 11, 2017
From: VALENT BIOSCIENCES CORPORATION
To: VALENT BIOSCIENCES LLC
Reel/Frame 042446/0583 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2013
From: HEIMAN, DANIEL F.; DEVISETTY, BALA; PETRACEK, PETER D.; LIU, XIAOZHONG; LOPEZ, JOHN; WOOLARD, DEREK D.; WANG, YUEH; VENBURG, GREGORY D.; WARRIOR, PREM
To: VALENT BIOSCIENCES CORPORATION
Reel/Frame 030445/0310 →